Skip to main content
  • News & events
  • Insights
  • Careers
  • Search
Sign in
Belgium
Home
  • About Fujirebio
  • Products & Solutions
  • CDMO (OEM)
  • Neuro
  • Home
  • About Fujirebio
  • Products & Solutions
  • Neuro
  • CDMO (OEM)
  • Quality
  • Insights
  • Resource Center
  • Sign in | register
  • News & Events
  • Careers
  • Contact
  • Home
  • Merger of ADx NeuroSciences NV and Fujirebio Europe NV

Merger of ADx NeuroSciences NV and Fujirebio Europe NV

Following the acquisition of ADx NeuroSciences NV by Fujirebio Europe NV in 2022, the merger will officially take effect on 1 April 2026.

What does this mean for ADx NeuroSciences NV customers?

  • All operations will be conducted under the name Fujirebio Europe NV.

  • Our commitment to deliver high-quality products and services remain unchanged. The integration of our teams allows us to better support you with an expanded portfolio and a broader range of expertise.

  • You will continue to have access to all familiar services and information via the Fujirebio website. 

For further reading, we recommend our Insight article:

  • Integration of ADx NeuroSciences Within Fujirebio Unleashes a World of New Possibilities

Do also feel free to contact us at any time at fnce@fujirebio.com.

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.
Home
  • Home
  • About Fujirebio
  • Products & Solutions
  • Neuro
  • CDMO (OEM)
  • Quality
  • Insights
  • News & Events
  • Careers
  • Contact
  • Resource Center
  • Sign in | register

Follow us on:

FUJIREBIO is an H.U. Group company.

  • © Fujirebio
  • Terms & Conditions
  • FDI-545 11/25
site by D'M&S
  • Home
  • About Fujirebio
    • Message from the CEO
    • Global Leadership
    • Fujirebio at a Glance
    • History
    • Sustainability and Social Responsability
  • Products & Solutions
  • Neuro
    • Diagnostic Tools for Alzheimer’s Disease
    • Medical Education
    • The Fujirebio Neuro Center of Excellence
    • NExT - the Neuro Expert Toolbox
  • CDMO (OEM)
    • Antibody Identification and Characterization
    • Antibody Supply
    • Contract Manufacturing
    • Product Development
    • Clinical Services
    • Regulatory Services
  • Quality
  • Insights
    • Webinars
  • News & Events
  • Careers
  • Contact
  • Resource Center
  • Product Documentation
  • Partner Portal
  • Sign in | register
Sign in